Search research articles
Contact Us
Filters
Showing results (21-30 of 181) with videos related to
Page
of 19
Sort By:
Expert Opinion on Therapeutic Targets
|
May 6, 2016
Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis
Bieke Van der Veken, Guido Ry De Meyer, Wim Martinet
Basic Research in Cardiology
|
May 26, 2011
Necrotic cell death in atherosclerosis
Wim Martinet, Dorien M Schrijvers, Guido R Y De Meyer
Heart Failure Reviews
|
April 13, 2010
Role of autophagy in heart failure associated with aging
Guido R Y De Meyer, Gilles W De Keulenaer, Wim Martinet
Frontiers in Pharmacology
|
April 26, 2019
Macrophage Death as a Pharmacological Target in Atherosclerosis
Wim Martinet, Isabelle Coornaert, Pauline Puylaert, et al.
Vascular Pharmacology
|
October 29, 2017
Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice
Bieke Van der Veken, Guido R Y De Meyer, Wim Martinet
World Journal of Gastroenterology
|
June 27, 2014
Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue
Wilhelmus J Kwanten, Wim Martinet, Peter P Michielsen, et al.
Nature Reviews. Cardiology
|
January 1, 2024
Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets
Guido R Y De Meyer, Michelle Zurek, Pauline Puylaert, et al.
Free Radical Research
|
May 8, 2010
Comparative EPR study of different macrophage types stimulated for superoxide and nitric oxide production
Maartje Deschacht, Tessa Horemans, Wim Martinet, et al.
Frontiers in Cardiovascular Medicine
|
January 22, 2024
Plasma levels of autophagy regulator Rubicon are inversely associated with acute coronary syndrome
Marie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
Journal of Molecular and Cellular Cardiology Plus
|
January 13, 2025
Circulating autophagy regulator Rubicon is linked to increased myocardial infarction risk
Marie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
Page
of 19
Search research articles
Search
Showing results (21-30 of 181) with videos related to
Sort By:
Page
of 19
Expert Opinion on Therapeutic Targets
|
May 6, 2016
Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis
Bieke Van der Veken, Guido Ry De Meyer, Wim Martinet
Basic Research in Cardiology
|
May 26, 2011
Necrotic cell death in atherosclerosis
Wim Martinet, Dorien M Schrijvers, Guido R Y De Meyer
Heart Failure Reviews
|
April 13, 2010
Role of autophagy in heart failure associated with aging
Guido R Y De Meyer, Gilles W De Keulenaer, Wim Martinet
Frontiers in Pharmacology
|
April 26, 2019
Macrophage Death as a Pharmacological Target in Atherosclerosis
Wim Martinet, Isabelle Coornaert, Pauline Puylaert, et al.
Vascular Pharmacology
|
October 29, 2017
Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice
Bieke Van der Veken, Guido R Y De Meyer, Wim Martinet
World Journal of Gastroenterology
|
June 27, 2014
Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue
Wilhelmus J Kwanten, Wim Martinet, Peter P Michielsen, et al.
Nature Reviews. Cardiology
|
January 1, 2024
Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets
Guido R Y De Meyer, Michelle Zurek, Pauline Puylaert, et al.
Free Radical Research
|
May 8, 2010
Comparative EPR study of different macrophage types stimulated for superoxide and nitric oxide production
Maartje Deschacht, Tessa Horemans, Wim Martinet, et al.
Frontiers in Cardiovascular Medicine
|
January 22, 2024
Plasma levels of autophagy regulator Rubicon are inversely associated with acute coronary syndrome
Marie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
Journal of Molecular and Cellular Cardiology Plus
|
January 13, 2025
Circulating autophagy regulator Rubicon is linked to increased myocardial infarction risk
Marie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
Page
of 19